Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients

被引:0
|
作者
Jian Yu Xu
Qing Hong Dan
Vivian Chan
Nelson M S Wat
Sidney Tam
Sau Cheung Tiu
Ka Fai Lee
Shing Chung Siu
Man Wo Tsang
Lai Ming Fung
Kin Wah Chan
Karen S L Lam
机构
[1] University of Hong Kong,Department of Medicine
[2] Queen Mary Hospital,Clinical Biochemistry Unit
[3] University of Hong Kong,Department of Medicine
[4] Queen Mary Hospital,Department of Medicine
[5] Queen Elizabeth Hospital,Department of Medicine
[6] Kwong Wah Hospital,Department of Medicine
[7] Tung Wah Eastern Hospital,Department of Medicine
[8] United Christian Hospital,Department of Medicine
[9] Caritas Medical Centre,undefined
[10] Princess Margaret Hospital,undefined
来源
关键词
maturity-onset diabetes of the young; obesity; insulin resistance; Chinese;
D O I
暂无
中图分类号
学科分类号
摘要
In Caucasians, maturity-onset diabetes of the young (MODY) is mostly caused by mutations in the hepatocyte nuclear factor (HNF)-1α (MODY3) and glucokinase (MODY2) genes. Most Japanese MODY patients, however, are not linked to known MODY genes. In this study, we examined the genetic and clinical characteristics of Chinese subjects with MODY. The study included 146 unrelated families fulfilling the minimum criteria for MODY: two consecutive generations of type II diabetes with at least one member diagnosed under the age of 25. We screened for mutations in the HNF-4α (MODY1), MODY2 and MODY3 genes by direct sequencing. Antibody to glutamic acid decarboxylase (GAD-Ab) was measured in subjects with MODY of unknown cause (MODYX). Insulin resistance index and other clinical data were compared in sex-, age- and duration-matched MODY3 and MODYX patients. In all, 13 families had MODY3 mutations and two had MODY2 mutations. No MODY1 mutation was found. Four of the 12 different MODY3 mutations were newly identified novel mutations (Q243E, A311D, P379R and P488fsdelC). In subjects with MODYX, 3% were GAD-Ab positive and 60% were overweight. Compared to MODY3 patients, MODYX patients had higher body mass index (P<0.02), higher insulin resistance index (P=0.001) and triglyceride level (P<0.02), lower HDL level (P=0.001) and more hypertension (P<0.05), but no significant difference in the prevalence of diabetic complications. In conclusion, MODY3 and MODY2 account for only 9 and 1%, respectively, of Chinese MODY. A majority of Chinese MODY patients are due to defects in unknown genes and appear to be characterized by insulin resistance.
引用
收藏
页码:422 / 427
页数:5
相关论文
共 50 条
  • [31] Maturity-onset diabetes of the young: An update
    Olek, Klaus
    CLINICAL LABORATORY, 2006, 52 (11-12) : 593 - 598
  • [32] Maturity-onset diabetes of the young (MODY)
    Bobadilla-Olaje G.F.
    Calleja-López J.R.T.
    Ruibal-Tavares E.
    Rivera-Rosas C.N.
    Aguilera-Duarte L.J.
    Radwaste Solutions, 2022, 89 (02): : 27 - 31
  • [33] Management of Maturity-Onset Diabetes of the Young
    Botero, Diego
    IATREIA, 2009, 22 (02) : 143 - 146
  • [34] Transcriptomic analysis of patients with clinical suspicion of maturity-onset diabetes of the young (MODY) with a negative genetic diagnosis
    María E. Vázquez-Mosquera
    Emiliano González-Vioque
    Sofía Barbosa-Gouveia
    Diego Bellido-Guerrero
    Cristina Tejera-Pérez
    Miguel A. Martinez-Olmos
    Antía Fernández-Pombo
    Luis A. Castaño-González
    Roi Chans-Gerpe
    María L. Couce
    Orphanet Journal of Rare Diseases, 17
  • [35] Update on clinical screening of maturity-onset diabetes of the young (MODY)
    Peixoto-Barbosa, Renata
    Reis, Andre F.
    Giuffrida, Fernando M. A.
    DIABETOLOGY & METABOLIC SYNDROME, 2020, 12 (01):
  • [36] Clinical utility gene card for: Maturity-onset diabetes of the young
    Kevin Colclough
    Cécile Saint-Martin
    José Timsit
    Sian Ellard
    Christine Bellanné-Chantelot
    European Journal of Human Genetics, 2014, 22 : 1153 - 1153
  • [37] Update on clinical screening of maturity-onset diabetes of the young (MODY)
    Renata Peixoto-Barbosa
    André F. Reis
    Fernando M. A. Giuffrida
    Diabetology & Metabolic Syndrome, 12
  • [38] Clinical utility gene card for: Maturity-onset diabetes of the young
    Colclough, Kevin
    Saint-Martin, Cecile
    Timsit, Jose
    Ellard, Sian
    Bellanne-Chantelot, Christine
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2014, 22 (09) : E1 - E6
  • [39] Necrobiosis lipodica is a clinical feature of maturity-onset diabetes of the young
    Stride, A
    Lambert, P
    Burden, ACF
    Mansell, P
    Page, S
    Hattersley, AT
    DIABETES CARE, 2002, 25 (07) : 1249 - 1250
  • [40] Molecular diagnosis of maturity-onset diabetes of the young in a cohort of Chinese children
    Xu, Aijing
    Lin, Yunting
    Sheng, Huiying
    Cheng, Jing
    Mei, Huifen
    Ting, Tzer Hwu
    Zeng, Chunhua
    Liang, Cuili
    Zhang, Wen
    Li, Cuiling
    Li, Xiuzhen
    Liu, Li
    PEDIATRIC DIABETES, 2020, 21 (03) : 431 - 440